Clinical trial
Relevance of Reversible Causes During OHCA (Rebecca Study)
NCT05784480 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Relevance of Reversible Causes During OHCA (Rebecca Study)
- Lead sponsor
- Medical University of Vienna
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- April 1, 2023
- Completion date
- December 31, 2026
- Enrollment
- 100 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cardiopulmonary arrest, out-of-hospital cardiac arrest